Crinetics Pharmaceuticals (CRNX) Stock Chart & Stock Price History $37.48 +0.62 (+1.67%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$37.47 -0.01 (-0.02%) As of 02/21/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Crinetics Pharmaceuticals Stock Price Performance 5 Day Performance+6.44%1 Month Performance-3.03%3 Month Performance-33.15%6 Month Performance-29.61%Year-To-Date Performance-26.70%1 Year Performance+2.06% Receive CRNX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address CRNX Stock Chart for Saturday, February, 22, 2025 CRNX Chart by TradingView Crinetics Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/21/2025$36.86$37.48+1.67%$37.58$36.70928,933 shs$3.48 billion02/20/2025$36.60$36.86+0.71%$36.99$35.72588,017 shs$3.39 billion02/19/2025$35.53$36.60+3.01%$36.74$35.10571,369 shs$3.39 billion02/18/2025$35.21$35.53+0.91%$36.48$35.29841,448 shs$3.30 billion02/17/2025$35.21$35.21$35.63$34.64643,625 shs$3.27 billion02/14/2025$35.26$35.21-0.14%$35.63$34.64643,625 shs$3.27 billion02/13/2025$35.21$35.26+0.14%$35.85$35.07564,436 shs$3.27 billion02/12/2025$34.93$35.21+0.80%$35.22$34.07739,293 shs$3.27 billion02/11/2025$36.53$34.93-4.38%$36.66$34.42744,386 shs$3.24 billion02/10/2025$36.98$36.53-1.22%$37.54$36.48698,409 shs$3.39 billion Get the Latest News and Ratings for CRNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 02/07/2025$38.71$36.98-4.47%$39.18$36.69666,901 shs$3.43 billion02/06/2025$39.30$38.71-1.50%$39.72$38.42691,116 shs$3.59 billion02/05/2025$40.40$39.30-2.72%$40.88$38.92614,538 shs$3.64 billion02/04/2025$38.79$40.40+4.15%$40.61$38.51707,838 shs$3.75 billion02/03/2025$40.30$38.79-3.75%$40.01$38.72731,705 shs$3.60 billion01/31/2025$40.26$40.30+0.10%$41.07$39.72913,865 shs$3.74 billion01/30/2025$39.38$40.26+2.23%$40.66$39.38736,093 shs$3.73 billion01/29/2025$38.22$39.38+3.04%$39.75$37.82881,321 shs$3.65 billion01/28/2025$38.21$38.22+0.03%$39.15$37.88808,335 shs$3.54 billion01/27/2025$38.79$38.21-1.50%$40.26$37.881.07 million shs$3.54 billion01/24/2025$39.20$38.79-1.05%$39.77$38.29805,266 shs$3.60 billion01/23/2025$38.65$39.20+1.42%$39.38$37.70938,795 shs$3.64 billion01/22/2025$38.76$38.65-0.28%$41.45$38.251.87 million shs$3.58 billion01/21/2025$37.35$38.76+3.78%$39.08$37.411.24 million shs$3.59 billion Related Companies Viatris Stock Chart Moderna Stock Chart Dr. Reddy's Laboratories Stock Chart Vaxcyte Stock Chart Sarepta Therapeutics Stock Chart Qiagen Stock Chart Ascendis Pharma A/S Stock Chart Roivant Sciences Stock Chart Revolution Medicines Stock Chart Legend Biotech Stock Chart Receive CRNX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CRNX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crinetics Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Crinetics Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRNX Stock Alerts